160 related articles for article (PubMed ID: 3131440)
1. Urokinase- and tissue-type plasminogen activators in keratinocytes during wound reepithelialization in vivo.
Grøndahl-Hansen J; Lund LR; Ralfkiaer E; Ottevanger V; Danø K
J Invest Dermatol; 1988 Jun; 90(6):790-5. PubMed ID: 3131440
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical localization of urokinase- and tissue-type plasminogen activators in psoriatic skin.
Grøndahl-Hansen J; Ralfkiaer E; Nielsen LS; Kristensen P; Frentz G; Danø K
J Invest Dermatol; 1987 Jan; 88(1):28-32. PubMed ID: 3098860
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical localization of urokinase-type plasminogen activator in Sertoli cells and tissue-type plasminogen activator in spermatogenic cells in the rat seminiferous epithelium.
Vihko KK; Kristensen P; Danø K; Parvinen M
Dev Biol; 1988 Mar; 126(1):150-5. PubMed ID: 3125078
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of urokinase-type plasminogen activator and its type-1 inhibitor during healing of mouse skin wounds.
Rømer J; Lund LR; Eriksen J; Ralfkiaer E; Zeheb R; Gelehrter TD; Danø K; Kristensen P
J Invest Dermatol; 1991 Nov; 97(5):803-11. PubMed ID: 1919045
[TBL] [Abstract][Full Text] [Related]
5. The expression of plasminogen activator system in a rat model of periodontal wound healing.
Xiao Y; Li H; Bunn C; Bartold PM
J Periodontol; 2001 Jul; 72(7):849-57. PubMed ID: 11495131
[TBL] [Abstract][Full Text] [Related]
6. Epidermal plasminogen activator is abnormal in cutaneous lesions.
Jensen PJ; Baird J; Morioka S; Lessin S; Lazarus GS
J Invest Dermatol; 1988 Jun; 90(6):777-82. PubMed ID: 3131439
[TBL] [Abstract][Full Text] [Related]
7. The receptor for urokinase-type plasminogen activator is expressed by keratinocytes at the leading edge during re-epithelialization of mouse skin wounds.
Rømer J; Lund LR; Eriksen J; Pyke C; Kristensen P; Danø K
J Invest Dermatol; 1994 Apr; 102(4):519-22. PubMed ID: 8151132
[TBL] [Abstract][Full Text] [Related]
8. Plasminogen activator inhibitor-type 1 in Lewis lung carcinoma.
Kristensen P; Pyke C; Lund LR; Andreasen PA; Danø K
Histochemistry; 1990; 93(6):559-66. PubMed ID: 2109745
[TBL] [Abstract][Full Text] [Related]
9. Growth factors, tissue and urokinase-type plasminogen activators in venous ulcers.
Lagattolla NR; Stacey MC; Burnand KG; Gaffney PG
Ann Cardiol Angeiol (Paris); 1995; 44(6):299-303. PubMed ID: 7574362
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of urokinase-type plasminogen activator (uPA), its receptor (uPA-R), and inhibitor type-2 (PAI-2) during differentiation of keratinocytes in an organotypic coculture system.
Schaefer BM; Stark HJ; Fusenig NE; Todd RF; Kramer MD
Exp Cell Res; 1995 Oct; 220(2):415-23. PubMed ID: 7556451
[TBL] [Abstract][Full Text] [Related]
11. Differential regulation of plasminogen activation in normal keratinocytes and SCC-4 cells by fibroblasts.
Boxman IL; Quax PH; Löwik CW; Papapoulos SE; Verheijen J; Ponec M
J Invest Dermatol; 1995 Mar; 104(3):374-8. PubMed ID: 7861005
[TBL] [Abstract][Full Text] [Related]
12. [Tumor-associated prognostic factors of the plasminogen activator family: determination and clinical value of u-PA, t-PA, PAI-1, and PAI-2].
Mengele K; Harbeck N; Reuning U; Magdolen V; Schmitt M
Hamostaseologie; 2005 Aug; 25(3):301-10. PubMed ID: 16113755
[TBL] [Abstract][Full Text] [Related]
13. Urokinase-type plasminogen activator in endothelial cells during acute inflammation of the appendix.
Grøndahl-Hansen J; Kirkeby LT; Ralfkiaer E; Kristensen P; Lund LR; Danø K
Am J Pathol; 1989 Oct; 135(4):631-6. PubMed ID: 2508479
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical characterization of the plasminogen activator system in psoriatic epidermis.
Gissler HM; Frank R; Kramer MD
Br J Dermatol; 1993 Jun; 128(6):612-8. PubMed ID: 7687853
[TBL] [Abstract][Full Text] [Related]
15. Molecular characterization of plasminogen activators in human gingival crevicular fluid.
Brown JM; Watanabe K; Cohen RL; Chambers DA
Arch Oral Biol; 1995 Sep; 40(9):839-45. PubMed ID: 8651888
[TBL] [Abstract][Full Text] [Related]
16. Enzyme-linked immunosorbent assay for human urokinase-type plasminogen activator and its proenzyme using a combination of monoclonal and polyclonal antibodies.
Nielsen LS; Grøndahl-Hansen J; Andreasen PA; Skriver L; Zeuthen J; Danø K
J Immunoassay; 1986; 7(3):209-28. PubMed ID: 3091639
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D3 and calcipotriol decrease extracellular plasminogen activator activity in cultured keratinocytes.
Koli K; Keski-Oja J
J Invest Dermatol; 1993 Nov; 101(5):706-12. PubMed ID: 8228332
[TBL] [Abstract][Full Text] [Related]
18. Plasminogen activators in human nasal polyps and mucosa.
Larsen K; de Maat MP; Jespersen J
Rhinology; 1997 Dec; 35(4):175-7. PubMed ID: 9532638
[TBL] [Abstract][Full Text] [Related]
19. Plasminogen activation in healing human wounds.
Schäfer BM; Maier K; Eickhoff U; Todd RF; Kramer MD
Am J Pathol; 1994 Jun; 144(6):1269-80. PubMed ID: 8203466
[TBL] [Abstract][Full Text] [Related]
20. Comparative study of plasminogen activators in cancers and normal mucosae of human urinary bladder.
Hasui Y; Suzumiya J; Marutsuka K; Sumiyoshi A; Hashida S; Ishikawa E
Cancer Res; 1989 Feb; 49(4):1067-70. PubMed ID: 2492205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
